[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550751":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":68,"collaborators":70,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":10,"enrollmentInfo":84,"targetDuration":87,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Regional Cardiology Center, The Copper Health Centre (MCZ),","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"OA Intervention",null,"All consecutive patients with moderate\u002F severely calcified coronary lesions who underwent PCI facilitated by the Orbital Atherectomy The decision to perform orbital atherectomy was left to the operator's dissertation after the detection of a moderate\u002Fseverely calcified lesion. Angiographic calcification was classified as moderate when it involved between 30% and 50% of the reference lesion diameter, and severe when it occupied over 50% of the reference diameter. When the initial assessment was based on IVUS finding lesion had to reach at least 2 points in the IVUS calcium score. There were no angiographic exclusion criteria regarding lesion anatomy such as the length, tortuosity, severity, or location. All procedural features(use additional lesion preparation technique; stent implantation parameters, periprocedural pharmacological therapy, use of intravascular imaging along with the left ventricular support device) were left to the discretion of the operator.",[13],"Procedure: PCI Facilitated with Orbital Atherectomy Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","PCI Facilitated with Orbital Atherectomy Device","Percutaneous coronary intervention for coronary artery disease supported by the Orbital Atherectomy Device",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Piotr Rola, MD; PhD","CONTACT","+48767211446","piotr.rola@gmail.com",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Adrian Włodarczak, Assoc Prof.","+48768460300","wlodarczak.adrian@gmail.com",[31,54],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Department of Cardiology, Provincial Specialized Hospital in Legnica","RECRUITING","Legnica","Lower Silesian Voivodeship","59-220","Poland","PL",{"type":40,"coordinates":41},"Point",[42,43],16.1619,51.21006,{"lat":43,"lon":42},[46,48,51],{"name":47,"role":23,"phone":24,"phoneExt":10,"email":25},"Piotr Rola, M.D; PhD",{"name":49,"role":23,"phone":24,"phoneExt":10,"email":50},"Lukasz Furtan, MD","lukas.furtan@gmail.com",{"name":52,"role":53,"phone":10,"phoneExt":10,"email":10},"Mateusz Barycki, MD","SUB_INVESTIGATOR",{"facility":55,"status":33,"city":56,"state":35,"zip":57,"country":37,"countryCode":38,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Department of Cardiology, The Copper Health Centre (MCZ)","Lubin","59-300",{"type":40,"coordinates":59},[60,61],16.20149,51.40089,{"lat":61,"lon":60},[64,65],{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},{"name":66,"role":23,"phone":28,"phoneExt":10,"email":67},"Szymon Włodarczak, M.D.","wlodarczak.szy@gmail.com",{"type":69,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[71],{"name":72,"class":73},"Department of Cardiology, Provincial Specialized Hospital in Legnica, 59-200 Legnica, Poland.","UNKNOWN","100550751","lower-silesian-orbital-atherectomy-registry-loar-100550751",false,"NCT06451146","Lower Silesian Orbital Atherectomy Registry (LOAR)","Evaluation of the Safety and Efficacy of Orbital Atherectomy (OA) for Calcified Lesions in Patients With Coronary Artery Disease: The Lower Silesian Orbital Atherectomy Registry (LOAR)","LOAR","Inclusion Criteria:\n\n* The presence of moderately to severely calcified lesions.\n\nExclusion Criteria:\n\n* Lack of patient consent\n* Target vessel perforation due to previous unsuccessful lesion preparation\n* Pregnancy","ALL","18 Years",{"count":85,"type":86},500,"ESTIMATED","5 Years","OBSERVATIONAL","The Lower Silesian Orbital Atherectomy Registry (LOAR), is an observational registry collecting all consecutive cases of percutaneous coronary intervention (PCI) performed with the support of the Orbital Atherectomy Device due to the presence of calcified lesion in coronary arteries. Data will be collected in two cooperating cardiac centers (Department of Cardiology, The Copper Health Center, Lubin, Poland, and Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland).",[91,92],"Safety Issues","Efficacy, Self",[94,95,96,97,98],"Percutaneous coronary interventions","Calcified Lesion","Coronary artery diseases","Orbital Atherectomy","Lesion preparation","2024-08-19",{"date":101,"type":102},"2024-08-21","ACTUAL",{"date":104,"type":102},"2022-05-01",{"date":106,"type":86},"2027-05-01",{"name":5,"class":6},2]